Arkowitz David
SEC CIK 1296999 · EDGAR
BoughtSold
Most active insiders at IBIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duran Felipe | CFO | $50.2K | — |
| 2 | Brenner Martin | See Remarks, Dir | $24.9K | — |
| 3 | Banjak Marc | CLO | $23.0K | — |
Arkowitz David made no open-market trades at IBIO in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-13 | 2025-01-10 | IBIO | iBio, Inc. | Arkowitz David | Dir | P - Purchase | $2.72 | +18.4K | 18.4K | New | +$50.0K | |
| DT | 2024-02-16 | 2024-02-15 | MCRB | Seres Therapeutics, Inc. | Arkowitz David | CFO | M - OptEx | — | +10.6K | 186.4K | +6% | — |
| DT | 2024-02-16 | 2024-02-16 | MCRB | Seres Therapeutics, Inc. | Arkowitz David | CFO | S - Sale+OE | $1.08 | -3,939 | 182.4K | -2% | -$4,254 |
| D | 2023-10-31 | 2023-10-27 | MCRB | Seres Therapeutics, Inc. | Arkowitz David | CFO | M - OptEx | $0.00 | +13.2K | 179.8K | +8% | $0 |
| D | 2023-10-31 | 2023-10-30 | MCRB | Seres Therapeutics, Inc. | Arkowitz David | CFO | S - Sale+OE | $1.35 | -4,066 | 175.8K | -2% | -$5,489 |
| 2023-05-01 | 2023-04-27 | MCRB | Seres Therapeutics, Inc. | Arkowitz David | CFO | A - Grant | $0.00 | +42.5K | 166.6K | +34% | $0 | |
| D | 2022-10-31 | 2022-06-15 | MCRB | Seres Therapeutics, Inc. | Arkowitz David | CFO | M - OptEx | $0.00 | +5,000 | 70.5K | +8% | $0 |
| D | 2022-10-31 | 2022-10-27 | MCRB | Seres Therapeutics, Inc. | Arkowitz David | CFO | A - Grant | $0.00 | +42.5K | 113.0K | +60% | $0 |
| 2022-07-06 | 2022-07-05 | MCRB | Seres Therapeutics, Inc. | Arkowitz David | CFO | A - Grant | $3.15 | +63.5K | 65.5K | +3,175% | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations